Alphalan
Alphalan (Melphalan 2/5 mg) — Cipla nitrogen mustard alkylator for multiple myeloma and ovarian cancer. Empty-stomach administration; cumulative myelosuppression.
✓ Lääketieteellinen tarkistus Morgan Ellis — Farmasian tutkija · 8 vuoden kokemus · Viimeisin arvio: toukokuu 2026
Pikavastaus
Alphalan — Melphalan 2/5 mg (Cipla Inc). Nitrogen mustard alkylator for multiple myeloma (oral and high-dose conditioning before stem cell transplant), ovarian cancer, neuroblastoma. Variable bioavailability — take on empty stomach.
Mitä saat MedsBasen kautta:
- WHO-GMP sertifioitu valmistaja
- Huomaamaton neutraali pakkaus
- Maailmanlaajuinen toimitus
- Yli 1 400 asiakkaan arvioima (lue arvostelut)
📦 Uudelleenlähetystakuu: jos tilauksesi ei ole saapunut 20 arkipäivän kuluessa lähetyksestä, lähetämme sen uudelleen ilman lisäkustannuksia. Lue käytäntö.
Miksi tilata MedsBasesta
Alphalan ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Cumulative myelosuppression — weekly FBC during induction. Stop if neutrophils <1500/μL or platelets <100,000/μL. Cumulative dose limit relates to risk of secondary AML/MDS (~5-10% lifetime risk in long-term users). Take on empty stomach (food halves bioavailability).
Usein Kysytyt Kysymykset
When is this used?
Nitrogen mustard alkylator for multiple myeloma (oral and high-dose conditioning before stem cell transplant), ovarian cancer, neuroblastoma. Variable bioavailability — take on empty stomach. Specific protocols are oncologist-determined.
Sivuvaikutukset?
Class-typical: myelosuppression, nausea, alopecia, mucositis, fatigue. Specific toxicities depend on the drug — see safety boxes above.
Lääkeaineenvaihdunta?
Cancer chemotherapy has multiple critical interactions. Always disclose all medications including herbals and supplements. Anticoagulants, anticonvulsants, antibiotics, antifungals, and antivirals all need review.
Raskaus?
Cytotoxic chemotherapy is teratogenic. Effective contraception during and for 6 months after for both partners.
Monitoring?
Specialist-determined — typically FBC, renal/liver function, electrolytes before each cycle. Drug-specific tests (echocardiogram for anthracyclines, audiometry for cisplatin, etc.).
Mitä teen, jos unohdan ottaa annoksen?
Oral cytotoxics: skip the missed dose, do not double up, contact your oncology team. IV: dosing is strictly scheduled — discuss any delay or missed cycle with the specialist.
Storage?
Oral cytotoxics: at room temperature, away from children, in original blister. Hand washing after handling tablets. Pregnant household members should not handle broken tablets.
Vaccines?
Live vaccines are contraindicated during chemotherapy. Inactivated vaccines (annual influenza, pneumococcal) are recommended. Coordinate with oncology for timing.
Long-term complications?
Class-dependent: secondary malignancy, infertility, cardiotoxicity, neuropathy. Discuss with oncology — fertility preservation may be relevant before starting.
When is treatment finished?
Determined by tumour response, treatment intent (curative vs palliative), and toxicity. Imaging and clinical assessment guide ongoing therapy.
Other Cancer Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
More options in Anti Cancer Medication
Luokiteltu MedsBase-tilausmäärän mukaan — mitä muut asiakkaat tässä kategoriassa valitsevat.
| Vahvuus | 2 mg, 5 mg |
|---|---|
| Määrä | 25 Tablet/s, 50 Tablet/s, 75 Tablet/s |
| Lääkemuoto | Tabletti/tabletteja |
| Valmistaja | Natco Pharma |
| Hoito | Multiple myeloma |
| Geneerinen tuotemerkki | Melphalan |
Alphalan
Kysymykset ja vastaukset
Alphalan
Liittyvät tuotteet
Arvostelut
Ei vielä arvosteluja